Navigation Links
A trial to find out the effectiveness of biocides against Vespa velutina
Date:4/16/2013

The Monitoring Committee for the Asian hornet, the Vespa velutina, in which the Government of the Basque Autonomous Community (region), the Charter Provincial Councils, the Beekeeping sector and Neiker-Tecnalia are working together, will be taking steps aimed at controlling the Vespa velutina populations and minimizing their impact. This type of hornet is an invasive species from France that preys on bees and devastates beehives.

The Vespa velutina Monitoring Committee, which has been fighting to control this pest in the Basque Autonomous Community, has agreed to develop, through Neiker-Tecnalia, a controlled trial to assess the potential effectiveness on this insect of biocides tested in Chile for the Vspula germnica. This process will be carried out through the placing and controlled monitoring of baits, thus seeking to minimize the effects on other insect populations, birds and vertebrates.

Another of the steps will make it possible to find out the effect the Asian hornet is having on the viability and production of beehives by analysing the location of the Vespa velutina nests and determining its expansion and advances.

The Basque Government has initially earmarked 45,000 euros to fund these steps and has proposed action protocols with each of the parties involved in order to achieve progress.


'/>"/>

Contact: Irati Kortabitarte
i.kortabitarte@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Page: 1

Related biology news :

1. Sea level rise: Jeopardy for terrestrial biodiversity on islands
2. Mummy CT scans show preindustrial hunter gatherers had clogged arteries
3. Human trials for Streptococcus A vaccine
4. Manchester patients take part in pioneering heart attack blood test trial
5. MSU launches groundbreaking drug trial in Africa
6. Major clinical trial finds no link between genetic risk factors and 2 top wet AMD treatments
7. VIB applies for second poplar field trial
8. Canada launches first gene therapy trial for Fabry disease
9. £35 million to support research for vital industrial sector
10. New marker of drug response may speed pace of lung cancer prevention trials
11. New tuberculosis drug trial begins in South Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... a global expert in SoC-based imaging and computing solutions, has developed ... the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® , ... showcased during the upcoming Medtec Japan at Tokyo Big Sight April ... Vegas Convention Center April 24-27. ... Click here for an image of the M820 ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... , ... They call it the “hairy ball.” It’s an ... a system of linkages and connections so complex and dense that “it looks ... at Worcester Polytechnic Institute (WPI) and director of the university’s bioinformatics and computational ...
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces expanded coverage ... its newest module, US Hemostats & Sealants. , SmartTRAK’s US Market for Hemostats ... sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates the ...
(Date:10/11/2017)... LINDA, CA (PRWEB) , ... October 11, 2017 ... ... to upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding ... (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
Breaking Biology Technology: